デフォルト表紙
市場調査レポート
商品コード
1561041

微生物同定の市場規模、シェア、成長分析、製品・サービス別、手法別、技術別、地域別 - 産業予測、2024年~2031年

Microbial Identification Market Size, Share, Growth Analysis, By Product & Service, By Method, By Technology, By Region - Industry Forecast 2024-2031

出版日: | 発行: SkyQuest | ページ情報: 英文 157 Pages | 納期: 3~5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.86円
微生物同定の市場規模、シェア、成長分析、製品・サービス別、手法別、技術別、地域別 - 産業予測、2024年~2031年
出版日: 2024年09月17日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 目次
概要

微生物同定の世界市場規模は2022年に45億米ドルと評価され、2023年の50億6,000万米ドルから2031年には128億9,000万米ドルに成長し、予測期間(2024-2031年)のCAGRは12.40%で成長する見通しです。

世界の微生物同定市場は、感染症の罹患率の上昇と、微生物同定が病気の診断と治療に果たす重要な役割に対する意識の高まりにより、顕著な成長を遂げています。迅速かつ正確な同定方法に対する需要は、ヘルスケア、医薬品、飲食品、環境モニタリングなど様々な分野で高まっています。自動化システム、分子診断、ゲノミクスなどの技術革新は、微生物同定プロセスを大幅に強化し、より迅速で正確な結果を可能にしました。さらに、研究機関、バイオテクノロジー、製薬会社における微生物同定の使用の増加が市場を牽引しています。新たな感染症の出現や抗菌剤耐性に対する懸念の高まりにより、効果的な同定方法の必要性が強調され、この分野への投資が増加しています。さらに、個別化医療への注目とポイント・オブ・ケア検査の需要が市場の拡大に寄与しています。しかし、高度な同定技術に関連する高コストと熟練した専門家の不足が、成長への課題となっています。このようなハードルにもかかわらず、進行中の研究開発努力が世界の微生物同定市場を前進させ、イノベーションの機会を創出し、世界中の患者ケアを向上させることが期待されています。

目次

イントロダクション

  • 調査の目的
  • 定義
  • 市場範囲

調査手法

  • 情報調達
  • 二次データソースと一次データソース
  • 市場規模予測
  • 市場の想定と制限

エグゼクティブサマリー

  • 市場概要見通し
  • 供給需要動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
  • ポーターの分析

主な市場の考察

  • 技術分析
  • バリューチェーン分析
  • 市場のエコシステム
  • サプライチェーン分析
  • ケーススタディ分析
  • 規制情勢
  • イノベーションマトリクス
  • 主な投資の分析
  • 主な成功要因
  • 競合の程度

微生物同定市場:製品・サービス別

  • 市場概要
  • 機器とソフトウェア
  • 消耗品
    • パネル/IDカードとメディア
    • キット
    • その他の消耗品
  • サービス

微生物同定市場:方法別

  • 市場概要
  • 表現型分析法
  • プロテオミクスに基づく方法
  • 遺伝子型法

微生物同定市場:技術別

  • 市場概要
  • 質量分析に基づく微生物同定
  • PCRベース微生物同定
  • フローサイトメトリーベース微生物同定
  • 顕微鏡ベース微生物同定
  • その他の微生物同定技術

微生物同定市場:用途別

  • 市場概要
  • 診断用途
    • 人間の病気の診断
    • 動物の病気の診断
  • 医薬品用途
  • 食品検査
  • 飲料検査
  • 化粧品およびパーソナルケア製品の試験
  • 環境用途
  • その他の用途

微生物同定市場:エンドユーザー別

  • 病院、診断研究所、血液銀行
  • 製薬会社および受託研究機関
  • 食品製造会社
  • 飲料製造会社
  • その他のエンドユーザー

微生物同定市場規模:地域別

  • 市場概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ(MEA)
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ地域

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主な市場企業が採用した戦略
  • 市場における最近の活動
  • 主要企業の市場シェア(2023年)

主要企業プロファイル

  • bioMerieux SA(France)
  • Becton, Dickinson and Company(BD)(US)
  • Thermo Fisher Scientific Inc.(US)
  • Danaher Corporation(US)
  • Merck KGaA(Germany)
  • Bruker Corporation(US)
  • Shimadzu Corporation(Japan)
  • Qiagen NV(Netherlands)
  • Avantor, Inc.(US)
  • Accelerate Diagnostics, Inc.(US)
  • Biolog, Inc.(US)
  • Liofilchem S.r.l.(Italy)
  • Trivitron Healthcare(India)
  • Gradian Diagnostics(US)
  • Alifax S.r.l.(Italy)
  • HiMedia Laboratories(India)
  • i2a SA(France)
  • Zhuhai DL Biotech Co., Ltd.(China)
  • GeneFluidics, Inc.(US)
  • Creative Diagnostics(US)
目次
Product Code: SQMIG35J2067

Global Microbial Identification Market size was valued at USD 4.5 billion in 2022 and is poised to grow from USD 5.06 billion in 2023 to USD 12.89 billion by 2031, growing at a CAGR of 12.40% during the forecast period (2024-2031).

The global microbial identification market is experiencing notable growth due to the rising incidence of infectious diseases and increasing awareness of the critical role microbial identification plays in disease diagnosis and treatment. The demand for rapid and accurate identification methods is growing across various sectors such as healthcare, pharmaceuticals, food and beverage, and environmental monitoring. Technological innovations, including automated systems, molecular diagnostics, and genomics, have significantly enhanced the microbial identification process, enabling faster and more precise results. The market is further driven by the increasing use of microbial identification in research institutions, biotechnology, and pharmaceutical companies. The emergence of new infectious diseases and the growing concern over antimicrobial resistance have underscored the need for effective identification methods, leading to increased investment in this field. Additionally, the focus on personalized medicine and the demand for point-of-care testing are contributing to the market's expansion. However, high costs associated with advanced identification technologies and a shortage of skilled professionals present challenges to growth. Despite these hurdles, ongoing research and development efforts are expected to drive the global microbial identification market forward, creating opportunities for innovation and enhancing patient care worldwide.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microbial Identification market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microbial Identification Market Segmental Analysis

Global Microbial Identification Market is segmented by Product & Service, Method, Technology, Application, End User, and region. Based on Product & Service, the market is segmented into Instruments & Software, Consumables, and Services. Based on Method, the market is segmented into Phenotypic Methods, Proteomics-Based Methods, and Genotypic Methods. Based on Technology, the market is segmented into Mass Spectrometry-Based Microbial Identification Market, PCR Based Microbial Identification Market, Flow Cytometry Based Microbial Identification Market, Microscopy Based Microbial Identification Market, and Other Microbial Identification Technologies. Based on Application, the market is segmented into Diagnostic Applications Pharmaceutical Applications, Food Testing, Beverage Testing, Cosmetics and Personal Care Products Testing, Environmental Applications, and Other Applications. Based on End User, the market is segmented into Hospitals, Diagnostic Laboratories, and Blood Banks, Pharmaceutical Companies & Contract Research Organizations, Food Manufacturing Companies, Beverage Manufacturing Companies, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Microbial Identification Market

A major factor driving the growth of the global microbial identification market is the rising prevalence of infectious diseases. The increasing number of infections worldwide has created a strong demand for precise and rapid microbial identification methods, essential for timely diagnosis and effective treatment. This growing need is further amplified by factors like population growth, globalization, and the emergence of new drug-resistant pathogens. These trends emphasize the critical role of reliable microbial identification in healthcare environments, as it aids in combating the spread of infections and ensuring appropriate medical interventions.

Restraints in the Global Microbial Identification Market

A significant restraint in the global microbial identification market is the high cost of advanced identification techniques. Although technological advancements have enhanced the precision and speed of microbial identification, these improvements often come with a hefty price. The expense of acquiring and maintaining advanced equipment, along with the costs of staff training and necessary consumables, can be a financial burden for many. This high cost presents particular challenges for smaller healthcare facilities and regions with limited resources, restricting their ability to adopt these advanced methods. As a result, the widespread implementation of cutting-edge microbial identification techniques is limited, which can slow down market growth to some extent.

Market Trends of the Global Microbial Identification Market

A notable trend in the microbial identification market is the growing adoption of automation and advanced technologies. Laboratories and healthcare facilities are increasingly utilizing automated systems, along with innovative tools such as molecular diagnostics, genomics, and artificial intelligence (AI), to improve the efficiency, precision, and speed of microbial identification. Automation helps streamline processes, minimizes human error, and supports high-throughput testing, resulting in faster and more accurate results. The integration of these advanced technologies provides researchers and clinicians with deeper insights, enabling them to make well-informed decisions and ultimately improve patient care. This trend is largely driven by the rising need for rapid, accurate identification methods, particularly in response to emerging infectious diseases, antimicrobial resistance, and the growing emphasis on personalized medicine.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Technology Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • Supply chain Analysis
  • Case study Analysis
  • Regulatory Landscape
  • Innovation Matrix
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Microbial Identification Market by Product & Service

  • Market Overview
  • Instruments & Software
  • Consumables
    • Panels/Id Cards & Media
    • Kits
    • Other Consumables
  • Services

Microbial Identification Market by Method

  • Market Overview
  • Phenotypic Methods
  • Proteomics-Based Methods
  • Genotypic Methods

Microbial Identification Market by Technology

  • Market Overview
  • Mass Spectrometry-Based Microbial Identification Market
  • Pcr Based Microbial Identification Market
  • Flow Cytometry Based Microbial Identification Market
  • Microscopy Based Microbial Identification Market
  • Other Microbial Identification Technologies

Microbial Identification Market by Application

  • Market Overview
  • Diagnostic Applications
    • Human Disease Diagnosis
    • Animal Disease Diagnosis
  • Pharmaceutical Applications
  • Food Testing
  • Beverage Testing
  • Cosmetics And Personal Care Products Testing
  • Environmental Applications
  • Other Applications

Microbial Identification Market, By End User

  • Hospitals, Diagnostic Laboratories, and Blood Banks
  • Pharmaceutical Companies & Contract Research Organizations
  • Food Manufacturing Companies
  • Beverage Manufacturing Companies
  • Other End Users

Microbial Identification Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • bioMerieux SA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (BD) (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bruker Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shimadzu Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Qiagen NV (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Avantor, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Accelerate Diagnostics, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biolog, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Liofilchem S.r.l. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Trivitron Healthcare (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gradian Diagnostics (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Alifax S.r.l. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HiMedia Laboratories (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • i2a SA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zhuhai DL Biotech Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GeneFluidics, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Creative Diagnostics (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments